Zobrazeno 1 - 10
of 1 405
pro vyhledávání: '"John J.V. McMurray"'
Autor:
Deewa Zahir Anjum, Anders N. Bonde, Emil Fosbol, Caroline Hartwell Garred, Gunnar Gislason, Mariam Elmegaard, Pauline Knigge, Christian Torp‐Pedersen, Charlotte Andersson, Marc A. Pfeffer, Pardeep S. Jhund, John J.V. McMurray, Mark C. Petrie, Lars Kober, Morten Schou
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 3406-3415 (2024)
Abstract Aims Chronic kidney disease (CKD) is a well‐established risk factor for heart failure (HF); however, patients with an estimated glomerular filtration rate (eGFR) eGFR ≥ 30 and eGFR eGFR ≥ 30 and 72.2% for patients with eGFR eGFR ≥ 30
Externí odkaz:
https://doaj.org/article/6b8fbb6729914fe9889e775549a568c0
Autor:
Jaclyn Carberry, Mark C. Petrie, Matthew M.Y. Lee, Katriona Brooksbank, Ross T. Campbell, Richard Good, Pardeep S. Jhund, Peter Kellman, Ninian N. Lang, Kenneth Mangion, Patrick B. Mark, Alex McConnachie, John J.V. McMurray, Barbara Meyer, Vanessa Orchard, Aadil Shaukat, Stuart Watkins, Paul Welsh, Naveed Sattar, Colin Berry, Kieran F. Docherty
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2001-2012 (2024)
Abstract Aims Patients with a reduced left ventricular ejection fraction (LVEF) following an acute myocardial infarction (MI) are at risk of progressive adverse cardiac remodelling that can lead to the development of heart failure and death. The earl
Externí odkaz:
https://doaj.org/article/2392cabc2be74029819f96fb1ade1e0f
Autor:
Kieran F. Docherty, John J.V. McMurray, Paul R. Kalra, John G.F. Cleland, Ninian N. Lang, Mark C. Petrie, Michele Robertson, Ian Ford
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 1875-1879 (2024)
Abstract Aims To explore the potential interaction between use of SGLT2 inhibitors and the increase in haemoglobin in patients randomized to intravenous iron or the control group in the IRONMAN (Effectiveness of Intravenous Iron Treatment versus Stan
Externí odkaz:
https://doaj.org/article/7b8685721c094d3f8713fa148d206e05
Autor:
Jawad H. Butt, Kirsty McDowell, Toru Kondo, Akshay S. Desai, Martin P. Lefkowitz, Milton Packer, Mark C. Petrie, Marc A. Pfeffer, Jean L. Rouleau, Muthiah Vaduganathan, Michael R. Zile, Pardeep S. Jhund, Lars Køber, Scott Solomon, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 65-77 (2024)
Abstract Aims Red cell distribution width (RDW) is a strong prognostic marker in patients with heart failure (HF) and reduced ejection fraction and other conditions. However, very little is known about its prognostic significance in HF with preserved
Externí odkaz:
https://doaj.org/article/cc3942df190d4a5ebb48c652a5cce4f4
Autor:
Ewa A. Jankowska, Tomas Andersson, Claudia Kaiser‐Albers, Biykem Bozkurt, Ovidiu Chioncel, Andrew J.S. Coats, Loreena Hill, Friedrich Koehler, Lars H. Lund, Theresa McDonagh, Marco Metra, Clemens Mittmann, Wilfried Mullens, Uwe Siebert, Scott D. Solomon, Maurizio Volterrani, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 10, Iss 4, Pp 2159-2169 (2023)
Abstract Although the development of therapies and tools for the improved management of heart failure (HF) continues apace, day‐to‐day management in clinical practice is often far from ideal. A Cardiovascular Round Table workshop was convened by
Externí odkaz:
https://doaj.org/article/1cd7ff3043da490da8be324b0bbff997
Autor:
Jean‐Claude Tardif, Jean Rouleau, Glenn M. Chertow, Ayman Al‐Shurbaji, Vera Lisovskaja, Stephanie Gustavson, Yanli Zhao, Nadia Bouabdallaoui, Akshay S. Desai, Alexander Chernyavskiy, Maria Evsina, Béla Merkely, John J.V. McMurray, Marc A. Pfeffer
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 1066-1076 (2023)
Abstract Aims Several patients with heart failure and reduced ejection fraction (HFrEF) do not receive renin–angiotensin–aldosterone system (RAAS) inhibitors at the recommended dose or at all, frequently due to actual or feared hyperkalaemia. Sod
Externí odkaz:
https://doaj.org/article/3f9decbc19424144b1f6cdc8f26cf6c0
Autor:
Marie‐Pierre Dubé, Olympe Chazara, Audrey Lemaçon, Géraldine Asselin, Sylvie Provost, Amina Barhdadi, Louis‐Philippe Lemieux Perreault, Ian Mongrain, Quanli Wang, Keren Carss, Dirk S. Paul, Jonathan W. Cunningham, Jean Rouleau, Scott D. Solomon, John J.V. McMurray, Salim Yusuf, Chris B. Granger, Carolina Haefliger, Simon deDenus, Jean‐Claude Tardif
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 2997-3008 (2022)
Abstract Aims The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) programme consisted of three parallel, randomized, double‐blind clinical trials comparing candesartan with placebo in patients with heart fail
Externí odkaz:
https://doaj.org/article/dc7585ebfd504c5a9e9d0d9c346c92fa
Autor:
João Pedro Ferreira, Brian L. Claggett, Kieran F. Docherty, Pardeep S. Jhund, Faiez Zannad, Scott D. Solomon, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 3655-3658 (2022)
Abstract Aims Data on long‐term treatment effects are scarce, despite the intent to use new therapies for many years and the need of patients, physicians and payers to have a better understanding of the lifetime benefits of treatments. The restrict
Externí odkaz:
https://doaj.org/article/d96549ef521b40958a7582c17c694329
Autor:
Michele Provenzano, Niels Jongs, Priya Vart, Bergur V. Stefánsson, Glenn M. Chertow, Anna Maria Langkilde, John J.V. McMurray, Ricardo Correa-Rotter, Peter Rossing, C. David Sjöström, Robert D. Toto, David C. Wheeler, Hiddo J.L. Heerspink
Publikováno v:
Kidney International Reports, Vol 7, Iss 3, Pp 436-443 (2022)
Introduction: Mineralocorticoid receptor antagonists (MRAs) and sodium–glucose cotransporter-2 (SGLT2) inhibitors reduce the risk of kidney failure in chronic kidney disease (CKD). We performed an analysis of the Dapagliflozin and Prevention of Adv
Externí odkaz:
https://doaj.org/article/1ea3200adb9746dca4e6abb643d67f2e
Autor:
R. Thomas Lumbers, Sonia Shah, Honghuang Lin, Tomasz Czuba, Albert Henry, Daniel I. Swerdlow, Anders Mälarstig, Charlotte Andersson, Niek Verweij, Michael V. Holmes, Johan Ärnlöv, Per Svensson, Harry Hemingway, Neneh Sallah, Peter Almgren, Krishna G. Aragam, Geraldine Asselin, Joshua D. Backman, Mary L. Biggs, Heather L. Bloom, Eric Boersma, Jeffrey Brandimarto, Michael R. Brown, Hans‐Peter Brunner‐La Rocca, David J. Carey, Mark D. Chaffin, Daniel I. Chasman, Olympe Chazara, Xing Chen, Xu Chen, Jonathan H. Chung, William Chutkow, John G.F. Cleland, James P. Cook, Simon deDenus, Abbas Dehghan, Graciela E. Delgado, Spiros Denaxas, Alexander S. Doney, Marcus Dörr, Samuel C. Dudley, Gunnar Engström, Tõnu Esko, Ghazaleh Fatemifar, Stephan B. Felix, Chris Finan, Ian Ford, Francoise Fougerousse, René Fouodjio, Mohsen Ghanbari, Sahar Ghasemi, Vilmantas Giedraitis, Franco Giulianini, John S. Gottdiener, Stefan Gross, Daníel F. Guðbjartsson, Hongsheng Gui, Rebecca Gutmann, Christopher M. Haggerty, Pim van derHarst, Åsa K. Hedman, Anna Helgadottir, Hans Hillege, Craig L. Hyde, Jaison Jacob, J. Wouter Jukema, Frederick Kamanu, Isabella Kardys, Maryam Kavousi, Kay‐Tee Khaw, Marcus E. Kleber, Lars Køber, Andrea Koekemoer, Bill Kraus, Karoline Kuchenbaecker, Claudia Langenberg, Lars Lind, Cecilia M. Lindgren, Barry London, Luca A. Lotta, Ruth C. Lovering, Jian'an Luan, Patrik Magnusson, Anubha Mahajan, Douglas Mann, Kenneth B. Margulies, Nicholas A. Marston, Winfried März, John J.V. McMurray, Olle Melander, Giorgio Melloni, Ify R. Mordi, Michael P. Morley, Andrew D. Morris, Andrew P. Morris, Alanna C. Morrison, Michael W. Nagle, Christopher P. Nelson, Christopher Newton‐Cheh, Alexander Niessner, Teemu Niiranen, Christoph Nowak, Michelle L. O'Donoghue, Anjali T. Owens, Colin N.A. Palmer, Guillaume Paré, Markus Perola, Louis‐Philippe Lemieux Perreault, Eliana Portilla‐Fernandez, Bruce M. Psaty, Kenneth M. Rice, Paul M. Ridker, Simon P.R. Romaine, Carolina Roselli, Jerome I. Rotter, Christian T. Ruff, Marc S. Sabatine, Perttu Salo, Veikko Salomaa, Jessica vanSetten, Alaa A. Shalaby, Diane T. Smelser, Nicholas L. Smith, Kari Stefansson, Steen Stender, David J. Stott, Garðar Sveinbjörnsson, Mari‐Liis Tammesoo, Jean‐Claude Tardif, Kent D. Taylor, Maris Teder‐Laving, Alexander Teumer, Guðmundur Thorgeirsson, Unnur Thorsteinsdottir, Christian Torp‐Pedersen, Stella Trompet, Danny Tuckwell, Benoit Tyl, Andre G. Uitterlinden, Felix Vaura, Abirami Veluchamy, Peter M. Visscher, Uwe Völker, Adriaan A. Voors, Xiaosong Wang, Nicholas J. Wareham, Peter E. Weeke, Raul Weiss, Harvey D. White, Kerri L. Wiggins, Heming Xing, Jian Yang, Yifan Yang, Laura M. Yerges‐Armstrong, Bing Yu, Faiez Zannad, Faye Zhao, Regeneron Genetics Center, Jemma B. Wilk, Hilma Holm, Naveed Sattar, Steven A. Lubitz, David E. Lanfear, Svati Shah, Michael E. Dunn, Quinn S. Wells, Folkert W. Asselbergs, Aroon D. Hingorani, Marie‐Pierre Dubé, Nilesh J. Samani, Chim C. Lang, Thomas P. Cappola, Patrick T. Ellinor, Ramachandran S. Vasan, J. Gustav Smith
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 5531-5541 (2021)
Abstract Aims The HERMES (HEart failure Molecular Epidemiology for Therapeutic targetS) consortium aims to identify the genomic and molecular basis of heart failure. Methods and results The consortium currently includes 51 studies from 11 countries,
Externí odkaz:
https://doaj.org/article/77600c13420346d3a1c4c66140b2a3c7